Allergy

Rhinitis and asthma represent hot topics for Allergy
pp. 1-4(4)
Authors: Bousquet, J.; Bieber, T.; Fokkens, W.; Kowalski, M. L.; Humbert, M.; Niggemann, B.; Simon, H.-U.

Asthma in Latin America: a public heath challenge and research opportunity
pp. 5-17(13)
Authors: Cooper, P. J.; Rodrigues, L. C.; Cruz, A. A.; Barreto, M. L.

Dysregulation of the stress response in asthmatic children
pp. 18-31(14)
Authors: Priftis, K. N.; Papadimitriou, A.; Nicolaidou, P.; Chrousos, G. P.

Mechanical strain increases cytokine and chemokine production in bronchial fibroblasts from asthmatic patients
pp. 32-39(8)
Authors: Le Bellego, F.; Perera, H.; Plante, S.; Chakir, J.; Hamid, Q.; Ludwig, M. S.

Total serum IgE levels are associated with ambient ozone concentration in asthmatic adults
pp. 40-46(7)
Authors: Rage, E.; Jacquemin, B.; Nadif, R.; Oryszczyn, M.-P.; Siroux, V.; Aguilera, I.; Kauffmann, F.; Künzli, N.

Plasma protein profiles in early asthmatic responses to inhalation allergen challenge
pp. 47-54(8)
Authors: Rhim, T.; Choi, Y.-S.; Nam, B.-Y.; Uh, S. T.; Park, J. S.; Kim, Y.-H.; Paik, Y.-K.; Park, C.-S.

Both allergic and nonallergic asthma are associated with increased FE_NO levels, but only in never-smokers
pp. 55-61(7)
Authors: Malinovschi, A.; Janson, C.; Högman, M.; Rolla, G.; Torén, K.; Norbäck, D.; Olin, A.-C.

Validation of a questionnaire for assessment of asthma patient knowledge and behaviour
pp. 62-71(10)
Authors: Trebuchon, F.; Duracinsky, M.; Chassany, O.; Delaire, C.; Eydoux, E.; Longin, J.; Demoly, P.

Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment
pp. 72-80(9)
Authors: van Rensen, E. L. J.; Evertse, C. E.; van Schadewijk, W. A. A. M.; van Wijngaarden, S.; Ayre, G.; Mauad, T.; Hiemstra, P. S.; Sterk, P. J.; Rabe, K. F.

Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis
pp. 81-84(4)
Authors: Humbert, M.; Boulet, L. P.; Niven, R. M.; Panahloo, Z.; Blogg, M; Ayre, G.

Pharmacotherapy of allergic rhinitis: a pharmaco-economic approach
pp. 85-95(11)
Authors: Simoens, S.; Laekeman, G.

Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps
pp. 96-103(8)
Authors: Ebbens, F. A.; Maldonado, M.; de Groot, E. J. J.; Alobid, I.; van Drunen, C. M.; Picado, C.; Fokkens, W. J.; Mullol, J.

Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps
pp. 104-111(8)
Authors: Lu, X.; Zhang, X. H.; Wang, H.; Long, X. B.; You, X. J.; Gao, Q. X.; Cui, Y. H.; Liu, Z.

Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis
pp. 112-117(6)
Authors: Bresciani, M.; Lalibertè, F.; Lalibertè, M. F.; Gramiccioni, C.; Bonini, S.

Predictors of bronchial hyperresponsiveness in chronic rhinosinusitis with nasal polyp
pp. 118-122(5)
Authors: Han, D. H.; Kim, S. W.; Cho, S. H.; Kim, D. Y.; Lee, C. H.; Kim, S. S.; Rhee, C. S.

Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three
pp. 123-148(26)
Authors: Aït-Khaled, N.; Pearce, N.; Anderson, H. R.; Ellwood, P.; Montefort, S.; Shah, J.

Clara cell 10-kDa protein expression in chronic rhinosinusitis and its cytokine-driven regulation in sinonasal mucosa
pp. 149-157(9)
Authors: Liu, Z.; Lu, X.; Zhang, X. H.; Bochner, B. S.; Long, X. B.; Zhang, F.; Wang, H.; Cui, Y. H.

Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients
pp. 158-165(8)
Authors: Bachert, C.; Kuna, P.; Sanquer, F.; Ivan, P.; Dimitrov, V.; Gorina, M. M.; van de Heyning, P.; Loureiro, A.

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy
pp. 166-171(6)
Authors: Didier, A.; Melac, M.; Montagut, A.; Lhéritier-Barrand, M.; Tabar, A.; Worm, M.

Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy
pp. 172-178(7)
Authors: Martínez-Gómez, J. M.; Johansen, P.; Rose, H.; Steiner, M.; Senti, G.; Rhyner, C.; Crameri, R.; Kündig, T. M.

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study
pp. 179-186(8)
Authors: Ott, H.; Sieber, J.; Brehler, R.; Fölster-Holst, R.; Kapp, A.; Klimek, L.; Pfaar, O.; Merk, H.

House dust mite allergy: complete removal of the provoking allergen is a primary therapeutic approach
pp. 187-188(2)
Authors: Kopp, M. V.; Niggemann, B; Forster, J

House dust mite control measures for asthma
pp. 189-189(1)
Authors: De Blay, F.; Barnig, C.; Ott, M.

Author's reply on: `House dust mite control measures for asthma'
pp. 190-190(1)
Authors: Gøtzsche, P. C.; Johansen, H. K.